Skip to main content

Table 3 Multivariate analysis of prognostic factors for EOC patients (PFS & OS)

From: Acylglycerol kinase promotes ovarian cancer progression and regulates mitochondria function by interacting with ribosomal protein L39

Outcomes

Variable

HR

P

95%CI

PFS

The volume of ascites

0.645

0.863

0.462–1.613

Peritoneal cytology

1.535

0.135

0.875–2.694

FIGO stage

2.359

0.008

1.255–4.435

AGK expression

1.726

0.050

1.000–2.981

Outcomes

Variable

HR

P

95%CI

OS

The volume of ascites

0.864

0.649

0.461–1.619

Peritoneal cytology

1.538

0.133

0.877–2.695

FIGO stage

2.268

0.011

1.211–4.246

AGK expression

1.802

0.036

1.038–3.127

  1. Abbreviations: LVSI Lymphovascular space invasion, CI Confident interval, HR Hazard ratio, OS Overall survival, PFS Progression-free survival
  2. P < 0.05 was considered statistically significant